ANTICOAGULANT treatment is winning for itself a firm place in the armamentarium against postoperative venous thrombosis and pulmonary embolism. This has been accomplished by the sheer weight of ...

In pulmonary embolism, systemic anticoagulation is the cornerstone treatment. Unless a specific contraindication exists, professional guidelines recommend LMWH and DOACs over UFH for the majority ...

The NHS dietician was diagnosed as probably having a Pulmonary Embolism – a blood clot in the lung – but died after she failed to receive the treatment she needed and which probably would have ...

A pulmonary embolism is the most common pathology of a pulmonary angiogram. Options for treatment of a pulmonary embolism include: Pulmonary angiography of the lungs involves tests that examine ...

In the era of DOACs, risk for CTEPH following pulmonary embolism is affected by multiple factors, including gender and heart load.

AngioDynamics, Inc. (ANGO), a New York-based medical technology company Monday announced the publication of results from the Acute ...

MANY clinical and experimental studies have been performed to study the etiology, diagnosis and treatment ... fat embolism," has been recognized. In documenting the first case of pulmonary and ...

(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient ...